Jennifer R Linden, PhD

Highlights

1
Fluids and barriers of the CNS · 2022
MMMichael MazzuccoJRJennifer R Linden
PMID: 35135557PMCID: PMC8822708DOISenior author38 citations
2
Toxins · 2023
MMMichael MazzuccoJRJennifer R Linden
PMID: 37505692PMCID: PMC10467094DOISenior author9 citations
3
Bio-protocol · 2020
MMMichael MazzuccoJRJennifer R Linden
PMID: 33659373PMCID: PMC7842667DOISenior author5 citations

17

11

4 grants

Co-I
Immune Privilege, CNS Autoimmunity, and Clostridium perfringens Epsilon Toxin
National Institute of Allergy and Infectious Diseases · 2023–2028
R01AI174064-01A1
PI
Myelin Repair Foundation - SRA
Myelin Repair Foundation · 2026–2027Contract
SRA 245677-01
PI
Harboring the Initial Trigger of Multiple Sclerosis
National Multiple Sclerosis Society · 2023–2026
RG-2207-39817
PI
Myelin Repair Foundation
Myelin Repair Foundation · 2024–2026Contract
SRA 240902-01

Completed grants (7)

KP
Biopharma Agreement with Astoria Biologica
Astoria Biologica · 2023–2025BioPharma Alliance
BP 234223-01
PI
SRA
Myelin Repair Foundation · 2023–2024Contract
SRA 233154-01
PI
Using Endothelial Microparticles to Study Real-Time Blood Brain Barrier Permeability in Multiple Sclerosis Patients
National Multiple Sclerosis Society · 2017–2022Fellowship
TA-1604-08444
PI
Evaluation of Myelin Derived Extracellular Vesicles in Plasma of Multiple Sclerosis Patients
Myelin Repair Foundation · 2021–2022Contract
SRA 215280-01
PI
SRA Part I Title: Evaluation of Microglia Derived Extracellular Vesicles in MS Patients with Chronic Active Lesions
Myelin Repair Foundation · 2019–2021Contract
SRA 202208-01
PI
SRA Part II Title: Evaluation of CNS Derived Extracellular Vesicles in MS Patients with Chronic Active Lesions
Myelin Repair Foundation · 2020–2021Contract
SRA 202580-01
PI
CNS Endothelial Cell Derived Extracellular Vesicles as Biomarkers and Messengers of BBB Permeability in MS
Myelin Repair Foundation · 2018–2019Contract
SRA 190368-01

Study Finds Bacterial Toxin May Trigger Multiple Sclerosis Onset and Relapse
March 24, 2023
A specific toxin-producing gut bacteria may be responsible for both triggering the onset of multiple sclerosis (MS) and ongoing disease activity.

Astoria Biologica, Inc.